Acute Porphyria Drugs

R01AD01 - Beclometasone

Not porphyrinogenic
NP

Rationale
Inducer of CYP 3A5. Probably no significant systemic exposure. Several references stating non-porphyrinogenicity of glucocorticoids.
Chemical description
Antiinflammatory halogenated glucocorticoide for local (nasal spray) treatment of allergic and vasomotor rhinitis. Low probability for systemic effects. EPI-list: safe. French list: authorized. South African list: use Kalman, Bonkowski: safe The Merck Manual: safe Tschudy DP, Lamon JM: Porphyrin metabolism and the porphyrias, in Bondy PK, Rosenberg LE (eds.): Duncans Diseases of Metabolism. Philadelphia, WB Saunders, 1980, p939: safe Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997: safe
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes R01A / R01AD or go back.
References
Tradenames

Beclometason Beclo-Rino · Beconase Acuoso Beclonasal Rinoclenil Otri Heuschnupfen Beclo-Aqua · Beclometasone · Beclometasone Hayfever Relief · Beconase Aqueous · Beconase Hayfever · Beconase Hayfever Relief for Adults · Care Hayfever Relief · Nasobec Aqueous · Nasobec Hayfever · Numark Hayfever Relief · Pollenase Hayfever · Pollenase Hayfever Relief for Adults · Rino Clenil · Vivabec Beconase Beclonasal Beclo · Beclomethasone Allergo Rhinathiol Beclonasal · Beclonasal Forte Beconase Beconase Beclonasal Beconase Beconase · Gnadion
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙